Synthesis, antiplasmodial activity and in silico molecular docking study of pinocembrin and its analogs
Tóm tắt
Malaria remains the major health problem responsible for many mortality and morbidity in developing countries. Because of the development of resistance by Plasmodium species, searching effective antimalarial agents becomes increasingly important. Pinocembrin is a flavanone previously isolated as the most active antiplasmodial compound from the leaves of Dodonaea angustifolia. For a better understanding of the antiplasmodial activity, the synthesis of pinocembrin and a great number of analogs was undertaken. Chalcones 5a-r were synthesized via Claisen-Schmidt condensation using 2,4-dibenzyloxy-6-hydroxyacetophenone and aromatic aldehydes as substrates under basic conditions. Cyclization of compounds 5a-r to the corresponding dibenzylated pinocembrin analogs 6a-r was achieved using NaOAc in EtOH under reflux. Catalytic hydrogenation using 10% Pd/C as catalyst in an H-Cube Pro was used for debenzylation to deliver 7a-l. The structures of the synthesized compounds were characterized using various physical and spectroscopic methods, including mp, UV, IR, NMR, MS and HRMS. The synthesized dibenzylated flavanones 6a-d, 6i and 7a were evaluated for their in vivo antiplasmodial activities against Plasmodium berghei infected mice. Molecular docking simulation and drug likeness properties of compounds 7a-l were assessed using AutoDock Vina and SwissADME, respectively. A series of chalcones 5a-r has been synthesized in yields ranging from 46 to 98%. Treatment of the chalcones 5a-r with NaOAc refluxing in EtOH afforded the dibenzylated pinocembrin analogs 6a-r with yields up to 54%. Deprotection of the dibenzylated pinocembrin analogs delivered the products 7a-l in yields ranging from 78 to 94%. The dibenzylated analogs of pinocembrin displayed percent inhibition of parastaemia in the range between 17.4 and 87.2% at 30 mg/kg body weight. The parastaemia inhibition of 87.2 and 55.6% was obtained on treatment of the infected mice with pinocembrin (7a) and 4’-chloro-5,7-dibenzylpinocembrin (6e), respectively. The mean survival times of those infected mice treated with these two compounds were beyond 14 days indicating that the samples suppressed P. berghei and reduced the overall pathogenic effect of the parasite. The molecular docking analysis of the chloro derivatives of pinocembrin revealed that compounds 7a-l show docking affinities ranging from – 8.1 to – 8.4 kcal/mol while it was -7.2 kcal/mol for chloroquine. Pinocembrin (7a) and 4’-chloro-5,7-dibenzyloxyflavanone (6e) displayed good antiplasmodial activity. The in silico docking simulation against P. falciparum dihydrofolate reductase-thymidylate synthase revealed that pinocembrin (7a) and its chloro analogs 7a-l showed better binding affinity compared with chloroquine that was used as a standard drug. This is in agreement with the drug-like properties of compounds 7a-l which fulfill Lipinski's rule of five with zero violations. Therefore, pinocembrin and its chloro analogs could serve as lead compounds for further antiplasmodial drug development.
Tài liệu tham khảo
Lubis IN. Contribution of Plasmodium knowlesi to multispecies human malaria infections in North Sumatera, Indonesia. J Infect Dis. 2017;215(7):1148–55.
Ayoola GA, Coker H, Adesegun S, Adepoju-Bello A, Obaweya K, Ezennia E, Atangbayila T. Phytochemical screening and antioxidant activities of some selected medicinal plants used for malaria therapy in southwestern nigeria. Trop J Pharm Res. 2008;7:1019–24.
Cropper ML, Haile M, Lampietti J, Poulos C, Whittington D. The demand for malaria vaccine: evidence from Ethiopia. J Dev Econ. 2009;75:303–18.
World Health Organization. World Malaria Report. Geneva: World Health Organization; 2012.
Rasul A, Millimouno FM, Eltay WA, Ali M, Li X. Pinocembrin: A Novel Natural Compound with Versatile Pharmacological and Biological Activities. Biomed Res Int. 2013. https://doi.org/10.1155/2013/379850.
Qingyun Y, Yuanfeng Y, Feng C, Yan Q, Wei L, Song W. Identification and synthesis of impurities in pinocembrin-A new drug for the treatment of ischemic stroke. Chin J Chem. 2012;30:1315–9.
Said MM, Azab SS, Saeed NM, Demerdash EE. Antifibrotic mechanism of pinocembrin: impact on oxidative stress inflammation and TGF-β/Smad inhibition in rats. Ann Hepatol. 2018;17(2):307–17.
Saad AAE, Tadros MG, Elsherbiny DA, Menze ET. Therapeutic effects of pinocembrin on indomethacin-induced gastric ulcer model in rat. Az J Pharm Sci. 2017;56:1–9.
Melaku Y, Worku T, Tadesse Y, Mekonnen Y, Schmidt J, Arnold N, Dagne E. Antiplasmodial Compounds from Leaves of Dodonaea angustifolia. Curr Bioact Compd. 2017;13:268–73.
Zhang M, Jagdmann GE, Zandt MV, Beckett P, Schroeter H. Enantioselective synthesis of orthogonally protected (2R,3R)-(-)-epicatechin derivatives, key intermediates in the de novo chemical synthesis of (-)-epicatechin glucuronides and sulfates. Tetrahedron. 2013;24:362–73.
Hull LA. The dibenzalacetone reaction revisited. J Chem Educ. 2001;78(2):226.
Dhar DN, Lal JB. Chalcones. Condensation of aromatic aldehydes with resacetophenone. J Org Chem. 1958;23(8):1159–61.
Mardiana L, Ardiansah B, Bakri R, Aziza NP. Utilization of eggshell-derived material as a solid base catalyst for efficient synthesis of substituted chalcones. J Teknol. 2017;79(5):175–82.
Kulkarni P, Wagh P, Zubaidha P. An improved and eco-friendly method for the synthesis of flavanone by the cyclization of 2’-hydroxy chalcone using methane sulphonic acid as catalyst. Chemistry Journal. 2012;2(3):106–10.
Harwood LM, Loftus GC, Oxford A, Thomson C. An improved procedure for cyclisation of chalcones to flavanones using celite supported potassium fluoride in methanol: total synthesis of bavachinin. Synth Commun. 1990;20(5):649–57.
Urgaonkar S, Pierre HS, Meir I, Lund H, Chaudhuri DR, Shaw JT. Synthesis of Antimicrobial Natural Products Targeting FtsZ:(±)-Dichamanetin and (±)-2′′′-Hydroxy-5′′-benzylisouvarinol-B. Org Lett. 2005;7(25):5609–12.
Ali Y, Manickam G, Ghosha A, Subramanian P. More efficient palladium hydrogenolysis of benzyl groups. Synth Commun. 2006;36:925–8.
Peters W. Drug resistance in Plasmodium berghei Vincke and Lips. 1948 I. Chloroquine resistance. Exp Parasitol. 1965;17(1):80–9.
Chinchilla M, Guerrero OM, Abarca G, Barrios M, Castro O. An in vivo model to study the anti-malaric capacity of plant extracts. Rev Biol Trop. 1998;46(1):1–7.
Krettli AU, Adebayo JO, Krettli LG. Testing of natural products and synthetic molecules aiming at new antimalarials. Curr Drug Targets. 2009;10(3):261–70.
Werbe LM. Synthesis and antimalarial and antitumor effects of 2-amino-4-(hydrazino and hydroxyamino)-6-[(aryl) thio] quinazolines. J Med Chem. 1987;30(11):2151–4.
Silva LFR. In vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivatives. Antimicrob Agents Chemother. 2015. https://doi.org/10.1128/AAC.05012-14.
Silva LR. Comparative in vitro and in vivo antimalarial activity of the indole alkaloids ellipticine, olivacine, cryptolepine and a synthetic cryptolepine analog. Phytomedicine. 2012;20(1):71–6.
Oliveira SQ, de Almeida MTR, Maraslis F, Silva IT, Sincero TCM, Palermo JA, Cabrera CM, Caro MSB, Simoes CMO, Schenkel EP. Isolation of three new ent-labdanediterpenes from Dodonaea viscosa Jacq. (Sapindaceae): preliminary evaluation of antiherpes activity. Phytochem Lett. 2012;5:500–5.
Nardos A, Makonnen E. In vivo antiplasmodial activity and toxicological assessment of hydroethanolic crude extract of Ajuga remota. Malar J. 2017;16(1):25.
Okokon JE, Effiong I, Ettebong E. In vivo antimalarial activities of ethanolic crude extracts and fractions of leaf and root of Carpolobialutea. Pak J Pharm Sci. 2011;24:57–61.
Ivanetich KM, Santi DV. Bifunctional thymidylate synthase-dihydrofolate reductase in protozoa. FASEB J. 1990;4:1591–7.
Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011;7:146–57.
Lipinski CA. Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions. Adv Drug Deliv Rev. 2016;101:34–41.
Zhao L, Jin H, Sun L, Piao H, Quan Z. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives. Bioorg Med Chem Lett. 2005;15:5027–9.
Council NR. Guide for the care and use of laboratory animals. Washington: National Academies Press; 2010.
Seeliger D, Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des. 2010;24:417–22.
Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455–61.